Hypomorphic Rag mutations can cause destructive midline granulomatous disease.
Suk See De Ravin, Edward W Cowen, Kol A Zarember...
https://pubmed.ncbi.nlm.nih.gov/20489056/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-16
3500
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying patients with abnormal immune function who experience recurrent or unusual infections or chronic inflammation. This includes inherited immune conditions like X-linked severe combined immunodeficiency, chronic granulomatous disease, leukocyte adhesion deficiency, and acquired conditions such as graft-versus-host disease. The study aims to understand the disease progression and organ involvement to help develop new diagnostic and treatment approaches. Participants include patients with immune dysfunction, their biologically related family members, and healthy adults who serve as controls. Patients and relatives undergo medical history reviews, physical examinations, and provide blood, saliva, and urine samples for genetic and laboratory studies. Healthy volunteers aged 18 to 85 provide samples for immune function research but not genetic testing. Follow-up visits may occur at 6 months and one year to monitor changes and response to any treatments. During the study, participants undergo various tests such as chest x-rays, CT scans, lung function tests, and dental, eye, and hearing examinations when appropriate. Researchers collect samples repeatedly to study immune function and organ involvement. The study measures disease patterns, organ damage, genetic links, and biochemical markers over up to one year. Participants may also be considered for additional clinical trials or long-term follow-up to further understand their conditions.
CONDITIONS
Evaluation of Patients With Immune Function Abnormalities
P
Patricia L Littel, R.N.
H
Harry L Malech, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 1 year
Participants undergo medical history review, physical exams, and provide blood, saliva, and urine samples. Specialized tests may include chest x-rays, CT scans, lung function, dental, eye, and hearing exams for some patients.
Initial and follow-up visits at 6 months and 1 year, or more frequently if needed
Duration - Up to 1 year or longer as medically needed
Participants have follow-up visits to update medical history, physical exams, and repeat sample collection. Researchers monitor disease progression, organ involvement, and immune function changes.
Follow-up visits at 6 months and 1 year, or more frequent visits if medically required
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Suk See De Ravin, Edward W Cowen, Kol A Zarember...
https://pubmed.ncbi.nlm.nih.gov/20489056/M Noguchi, H Yi, H M Rosenblatt...
https://pubmed.ncbi.nlm.nih.gov/8462096/Jennifer Strong, Rutha Adhanom, Caleb S Kim...
https://pubmed.ncbi.nlm.nih.gov/40178760/Christopher K Zalewski, H Jeffrey Kim, Carmen C Brewer...
https://pubmed.ncbi.nlm.nih.gov/42606118/J L Stephan, V Vlekova, F Le Deist...
https://pubmed.ncbi.nlm.nih.gov/8410508/J M Puck, S M Deschênes, J C Porter...
https://pubmed.ncbi.nlm.nih.gov/8401490/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor